Ability Pharma Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 17

Ability Pharma General Information

Description

Developer of medical therapies intended to focus on developing fully differentiated oral targeted anticancer compounds. The company's targeted therapies are drugs that kill cancer cells through the induction of robust cytotoxic autophagy, enabling doctors to improve the lives of the patients and cure them.

Contact Information

Formerly Known As
AB-Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Edifici Eureka, Campus de la UAB
  • 08193 Barcelona
  • Spain
+34 935 00 00 00

Ability Pharma Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ability Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ability Pharma‘s full profile, request access.

Request a free trial

Ability Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical therapies intended to focus on developing fully differentiated oral targeted anticancer compounds.
Drug Discovery
Barcelona, Spain
20 As of 2024
000.00
000.00 0000-00-00
0000000 0000 000.00

000000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
0000000000000
Burlington, MA
00 As of 0000
00000
00000 0000-00-00
00000000000 00000

000000

at nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000 000000000
New York, NY
00 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ability Pharma Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardurion Pharma Venture Capital-Backed Burlington, MA 00 00000 00000000000 00000
Volastra Venture Capital-Backed New York, NY 00 00000 0000000000 0 00000
Ona Therapeutics Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
Loxo Oncology Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden 00 000.00 0000000000 0 000.00
You’re viewing 5 of 12 competitors. Get the full list »

Ability Pharma Patents

Ability Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3163864-A1 A pharmaceutical combination for the treatment of a cancer Pending 10-Feb-2020 0000000000
AU-2021220258-A1 A pharmaceutical combination for the treatment of a cancer Pending 10-Feb-2020 0000000000
US-20230088704-A1 A pharmaceutical combination for the treatment of a cancer Pending 10-Feb-2020 0000000000
US-20220257554-A1 Pharmaceutical combination for the treatment of a cancer Pending 16-May-2017 0000000000
US-11260042-B2 Pharmaceutical combination for the treatment of cancer Active 16-May-2017 A61K31/201 0
To view Ability Pharma’s complete patent history, request access »

Ability Pharma Executive Team (15)

Name Title Board Seat Contact Info
Jordi Espadaler Ph.D Co-Founder & Scientific Advisor
Carles Domènech Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer & Executive Chairman
Marc Cortal MD Manager of Clinical Research
José Manuel Valadés Board Member & General Secretary
Gemma Fierro Vice President, Clinical & Regulatory Affairs
You’re viewing 5 of 15 executive team members. Get the full list »

Ability Pharma Board Members (10)

Name Representing Role Since
000000 000è0000 00 Ability Pharma Co-Founder, Chief Executive Officer, Chief Scientific Officer & Executive Chairman 000 0000
0000á0 00000000 Fitalent Board Member 000 0000
000é 000000 00000é Ability Pharma Board Member & General Secretary 000 0000
0000 0á00000-00000 Self Chairman 000 0000
000000 000000000 Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Ability Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ability Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ability Pharma‘s full profile, request access.

Request a free trial

Ability Pharma FAQs

  • When was Ability Pharma founded?

    Ability Pharma was founded in 2009.

  • Who is the founder of Ability Pharma?

    Jordi Espadaler Ph.D and Carles Domènech Ph.D are the founders of Ability Pharma.

  • Who is the CEO of Ability Pharma?

    Maribel Berges is the CEO of Ability Pharma.

  • Where is Ability Pharma headquartered?

    Ability Pharma is headquartered in Barcelona, Spain.

  • What is the size of Ability Pharma?

    Ability Pharma has 20 total employees.

  • What industry is Ability Pharma in?

    Ability Pharma’s primary industry is Drug Discovery.

  • Is Ability Pharma a private or public company?

    Ability Pharma is a Private company.

  • What is the current valuation of Ability Pharma?

    The current valuation of Ability Pharma is 000.00.

  • What is Ability Pharma’s current revenue?

    The current revenue for Ability Pharma is 000000.

  • How much funding has Ability Pharma raised over time?

    Ability Pharma has raised $32.3M.

  • Who are Ability Pharma’s investors?

    Capital Cell, CTI Life Sciences Fund, GESAMO, IVAMOSA, and Oncotherapy Private Investments are 5 of 19 investors who have invested in Ability Pharma.

  • Who are Ability Pharma’s competitors?

    Cardurion Pharma, Volastra, Ona Therapeutics, Loxo Oncology, and Gesynta Pharma are some of the 12 competitors of Ability Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »